Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Concert Pharmaceutic
(NQ:
CNCE
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Mar 3, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
8.300 (1)
Ask (Size)
9.000 (6)
Prev. Close
-
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
32,173,778
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Concert Pharmaceuticals Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA for the Treatment of Alopecia Areata
February 15, 2023
From
Concert Pharmaceuticals, Inc.
Via
Business Wire
CNCE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Concert Pharmaceuticals, Inc. Is Fair to Shareholders
February 13, 2023
From
Halper Sadeh LLC
Via
Business Wire
Performance
More News
Read More
Why Concert Pharmaceuticals Stock Rocketed Higher This Week
January 20, 2023
Via
The Motley Fool
CONCERT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Concert Pharmaceuticals, Inc. - CNCE
January 20, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
India-Based Sun Pharma Scoops Up Concert Pharmaceuticals For $576M Plus Milestones
January 19, 2023
Via
Benzinga
Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 19, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 19, 2023
Via
Benzinga
Concert Pharmaceuticals, Coeur Mining And Other Big Stocks Moving Higher On Thursday
January 19, 2023
Via
Benzinga
Concert Pharmaceuticals's Return On Capital Employed Insights
November 29, 2022
Via
Benzinga
Concert Pharma: Q3 Earnings Insights
November 07, 2022
Via
Benzinga
Dow Falls 200 Points; Jobless Claims Drop To 4-Month Low
January 19, 2023
Via
Benzinga
CNCE Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Concert Pharmaceuticals, Inc. Is Fair to Shareholders
January 19, 2023
From
Halper Sadeh LLC
Via
Business Wire
Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata
January 19, 2023
From
Concert Pharmaceuticals
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 18, 2023
Via
Benzinga
Is Ardelyx is A Buy After Slip in Early 2022
November 21, 2022
Via
MarketBeat
Exposures
Product Safety
Concert Pharmaceuticals Announces Presentation of Deuruxolitinib THRIVE-AA1 Phase 3 Study Results in Alopecia Areata During World Congress for Hair Research
November 21, 2022
From
Concert Pharmaceuticals, Inc.
Via
Business Wire
Concert Pharmaceuticals to Participate in Fireside Chat at the Jefferies London Healthcare Conference
November 09, 2022
From
Concert Pharmaceuticals
Via
Business Wire
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
November 08, 2022
Via
Benzinga
Concert Pharmaceuticals Reports Third Quarter 2022 Financial Results
November 07, 2022
From
Concert Pharmaceuticals, Inc.
Via
Business Wire
Concert Pharmaceuticals to Report Third Quarter 2022 Results on November 7, 2022
October 31, 2022
From
Concert Pharmaceuticals, Inc.
Via
Business Wire
Planet Labs, Core & Main And Some Other Big Stocks Moving Higher On Tuesday
September 13, 2022
Via
Benzinga
Concert Pharmaceuticals Announces Presentation of CTP-543 THRIVE-AA1 Phase 3 Data in Alopecia Areata During Late Breaking Session at EADV Congress
September 10, 2022
From
Concert Pharmaceuticals, Inc.
Via
Business Wire
Concert Pharmaceuticals to Present at H.C. Wainwright Global Investment Conference
September 06, 2022
From
Concert Pharmaceuticals, Inc.
Via
Business Wire
Bridges and Landmarks Across the USA Will Illuminate Blue Throughout the Month of September for Alopecia Areata
September 01, 2022
From
Concert Pharmaceuticals, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
August 25, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.